[Drug therapy in newborn infants and bilirubin encephalopathy].
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001663:Bilirubin / Q000097:blood / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced*; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D011485:Protein Binding; D012709:Serum Albumin
D000900:Anti-Bacterial Agents; D012709:Serum Albumin; D001663:Bilirubin
Medikamentöse Therapie bei Neugeborenen und Bilirubinenzephalopathie.